Lifevantage (NASDAQ:LFVN) affirms FY2025 Adj EPS guidance from $0.70-0.80 to $0.70-0.80 vs $0.72 analyst estimate. Affirms FY2025 sales outlook from $200.00 million-210.00 million to $200.00 million-210.00 million vs $204.80 million estimate.
Lifevantage Affirms FY2025 Adj EPS Guidance From $0.70-0.80 to $0.70-0.80 Vs $0.72 Est; Affirms FY2025 Sales Guidance From $200.00M-210.00M to $200.00M-210.00M Vs $204.80M Est
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated